The role of proprotein convertase subtilisin kexin 9 (PCSK9) in preeclampsia with severe features

被引：1

作者：

Bishop, Juliet ^{[1
]}

Shaddeau, Angela ^{[2
]}

Darwin, Kristin C. ^{[1
]}

Wilson, Tenisha ^{[1
]}

Boyer, Theresa ^{[1
]}

Debrosse, Alexia ^{[3
]}

Sharma, Garima ^{[1
]}

Vaidya, Dhananjay ^{[1
]}

Ouyang, Pamela ^{[1
]}

Mukherjee, Monica ^{[1
]}

Zakaria, Sammy ^{[1
]}

Leucker, Thorsten ^{[1
]}

Vaught, Arthur J. ^{[1
]}

机构：

[1] Johns Hopkins Sch Med, Baltimore, MD USA

[2] Johns Hopkins Sch Med, Germantown, MD USA

[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2020年 / 222卷 / 01期

关键词：

D O I：

10.1016/j.ajog.2019.11.888

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

875

引用

页码：S546 / S547

页数：2

共 50 条

[21] PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
Shimada, Yuichi J.
Cannon, Christopher P.
EUROPEAN HEART JOURNAL, 2015, 36 (36) : 2415 - U36
[22] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
O'Connell, Emma M.
Lohoff, Falk W.
FRONTIERS IN NEUROSCIENCE, 2020, 14
[23] Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Seidah, Nabil G.
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (17) : 3161 - 3172
[24] Genetic deficiency of proprotein convertase Subtilisin/Kexin 9: identification of a compound heterozygote with no PCSK9
Tuakli-Wosornu, Yetsa
Zhao, Zhenze
Lagace, Thomas
Horton, Jay
Cohen, Jonathan C.
Hobbs, Helen H.
CIRCULATION, 2006, 114 (18) : 187 - 187
[25] Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
Bhattacharya, Anindita
Chowdhury, Abhirup
Chaudhury, Koel
Shukla, Praphulla Chandra
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
[26] Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation
Basak, Ajoy
Palmer-Smith, Heather
Mishra, Priyambada
PROTEIN AND PEPTIDE LETTERS, 2012, 19 (06): : 575 - 585
[27] Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a novel psoriasis susceptibility locus
Merleev, A.
Toussi, A.
Downing, L.
Tran, M.
Nava, J.
Le, S.
Marusina, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S1 - S1
[28] Involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in aortic valvular calcification
Poggio, P.
Songia, P.
Chiesa, M.
Barbieri, S.
Moschetta, D.
Valerio, V.
Cavallotti, L.
Ferri, N.
Zanotti, I.
Camera, M.
EUROPEAN HEART JOURNAL, 2018, 39 : 1057 - 1057
[29] Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors: a district general hospitals experience
Whicher, C. A.
Tjerkstra, E.
Waise, A.
DIABETIC MEDICINE, 2017, 34 : 155 - 155
[30] The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process - is there a link?
Grobelna, Malwina K.
Strauss, Ewa
Krasinski, Zbigniew
KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 16 (03) : 128 - 132

← 1 2 3 4 5 →